Cargando…
TGF‐β signaling in liver metastasis
The presence of liver metastases drastically worsens the prognosis of cancer patients. The liver is the second most prevalent metastatic site in cancer patients, but systemic therapeutic opportunities that target liver metastases are still limited. To aid the discovery of novel treatment options for...
Autores principales: | Marvin, Dieuwke L, Heijboer, Rosan, ten Dijke, Peter, Ritsma, Laila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701955/ https://www.ncbi.nlm.nih.gov/pubmed/33252863 http://dx.doi.org/10.1002/ctm2.160 |
Ejemplares similares
-
TGF-β Type I Receptor Signaling in Melanoma Liver Metastases Increases Metastatic Outgrowth
por: Marvin, Dieuwke L., et al.
Publicado: (2023) -
TGF-β in progression of liver disease
por: Dooley, Steven, et al.
Publicado: (2011) -
TGFβ Signaling and Cardiovascular Diseases
por: Pardali, Evangelia, et al.
Publicado: (2012) -
TGF-β Signaling in Breast Cancer Cell Invasion and Bone Metastasis
por: Drabsch, Yvette, et al.
Publicado: (2011) -
Low Transforming Growth Factor-β Pathway Activity in Cervical Adenocarcinomas
por: Marvin, Dieuwke L., et al.
Publicado: (2022)